AYLA - Ayala Pharmaceuticals Inc
Close
0.5036
0.028 5.520%
Share volume: 0
Last Updated: Wed 18 Jan 2023 10:00:00 PM CET
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$0.48
0.03
5.84%
Summary score
33%
Profitability
48%
Dept financing
25%
Liquidity
49%
Performance
15%
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
1.07%
Return on assets
-26.72%
Return on sales
-638.04%
Return on invested capital
200.91%
Total debt ratio
204.38%
Debt ratio change over timeo
-0.96%
Current Ratio
5.95%
Quick Ratio
0%
Cash Position Ratio
5.75%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
1.07%
Return on assets
-26.72%
Return on sales
-638.04%
Return on invested capital
200.91%
Total debt ratio
204.38%
Debt ratio change over timeo
-0.96%
Current Ratio
5.95%
Quick Ratio
0%
Cash Position Ratio
5.75%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-12.44%
Return on assets
-10.97%
Return on sales
-632.82%
Return on invested capital
162.24%
Total debt ratio
10.48%
Debt ratio change over time
-0.96%
Current Ratio
10.13%
Quick Ratio
0%
Cash Position Ratio
9.93%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-105.19%
Return on assets
-104.58%
Return on sales
-364.14%
Return on invested capital
-32.28%
Total debt ratio
-95.62%
Debt ratio change over time
-0.96%
Current Ratio
3.23%
Quick Ratio
0%
Cash Position Ratio
3.14%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AYLA | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | 1.07% | -4.61% | -11.83% | 0% |
| Return on assets | -26.72% | -4.6% | -10.3% | 0% |
| Return on sales | -638.04% | -37.29% | 0% | 0% |
| Return on invested capital | 200.91% | 265.33% | -27.14% | 0% |
| Profitability | 44% | 25% | 25% | 25% |
| Total debt ratio | 204.38% | 18.22% | 14.3% | 0% |
| Debt ratio change over time | -0.96% | -1.66% | -1.56% | 0% |
| Dept financing | 25% | 2% | 2% | 25% |
| Current Ratio | 5.95% | 4.65% | 5.1% | 0% |
| Quick Ratio | 0% | 4.32% | 0% | 0% |
| Cash Position Ratio | 5.75% | 0.81% | 2.5% | 0% |
| Liquididy | 45% | 43% | 31% | 0% |
| Short-term ratios | AYLA | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | 1.07% | -3.62% | -13.55% | 0% |
| Return on assets | -26.72% | -3.93% | -11.56% | 0% |
| Return on sales | -638.04% | -34.27% | 0% | 0% |
| Return on invested capital | 200.91% | -9.88% | -24.84% | 0% |
| Profitability | 50% | 0% | 25% | 25% |
| Total debt ratio | 204.38% | 15.47% | 15.89% | 0% |
| Debt ratio change over time | -0.96% | -0.59% | -1.72% | 0% |
| Dept financing | 25% | 2% | 2% | 25% |
| Current Ratio | 5.95% | 4.65% | 5.1% | 0% |
| Quick Ratio | 0% | 4.32% | 0% | 0% |
| Cash Position Ratio | 5.75% | 0.81% | 2.5% | 0% |
| Liquididy | 50% | 48% | 32% | 0% |